CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
CITN11-02中期试验结果:皮下注射重组人IL-15 (rhIL-15) 与外周血CD56+ NK细胞和CD8+ T细胞扩增相关
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-017-0280-z
Kamat, Ashish M; Bellmunt, Joaquim; Galsky, Matthew D; Konety, Badrinath R; Lamm, Donald L; Langham, David; Lee, Cheryl T; Milowsky, Matthew I; O'Donnell, Michael A; O'Donnell, Peter H; Petrylak, Daniel P; Sharma, Padmanee; Skinner, Eila C; Sonpavde, Guru; Taylor, John A 3rd; Abraham, Prasanth; Rosenberg, Jonathan E; Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook E; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin C; Sondel, Paul M; Wakelee, Heather A; Apodaca, Minjun C; Fling, Steven P; Disis, Mary L; Creekmore, Stephen P; Miller, Jeffrey S
T细胞
CD5
CD8
T细胞
细胞生物学
CD56
IL-15
免疫/内分泌